New drug cocktail targets brain tumors in Late-Stage cancer
NCT ID NCT07449481
First seen Mar 08, 2026 · Last updated Jun 15, 2026 · Updated 18 times
Summary
This study tests a combination of two drugs (utidelone and bevacizumab), with or without a third (etoposide), in 56 people with brain metastases from lung or breast cancer. The goal is to see if this treatment can shrink brain tumors and control the disease. Participants must have certain cancer types and have tried prior therapies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN METASTASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.